Bronchopulmonary dysplasia (BPD) and very low birth weight (VLBW) are associated with increased incidences of asthma and pulmonary dysfunction in childhood. However, no studies exist which examine asthma risk factors in children who were VLBW infants and did not have BPD. To address this issue, we assessed the asthma incidence and risk factors for asthma in 117 children (approximate mean age of 5 years) who were VLBW w-1500 g, mean gestational age (GA): 30 weeksx infants without BPD. The risk factors were both perinatal (such as steroid treatment, mechanical ventilation, surfactant treatment) and environmental (parental smoking, pet adoption, etc). The asthma incidence was 18.8%. Following multivariate analysis, it was determined that a family history of atopy was a strong risk factor for childhood asthma. Maternal antenatal steroid treatment was associated with a significantly reduced risk for asthma. GA and birth weight were not predictive of childhood asthma. These findings indicate that a history of familial atopy and antenatal steroid treatment are positively and negatively associated (independent of BPD) with childhood asthma in VLBW infants. The finding regarding antenatal steroid treatment warrants more extensive investigations.
Introduction
Advances in neonatal intensive care strategies and technology markedly improved survival rates of very low birth weight (VLBW) w12x. Despite this, bronchopulmonary dysplasia (BPD) remains a major morbidity in such infants w10, 31, 32x. There is also growing concern, and indeed compelling evidence, about the long-term pulmonary consequences for VLBW infants who had BPD w5, 12, 18x.
There appears to be a strong link between BPD and later airway hyperresponsiveness in survivors w13x. There is also evidence suggesting that prematurity/low birth weight per se similarly leads to impaired lung development and pulmonary dysfunction w4, 7, 15x. In addition, a number of studies have reported an increased asthma risk in school-aged children who were VLBW infants w23, 24x. In these studies, however, it was not stated whether the VLBW infants were also afflicted with BPD. Therefore, the aim of the present study is to identify the perinatal and environmental risk factors associated with asthma and active wheezing in children who were VLBW infants but did not suffer from BPD.
Materials and methods
We identified 158 children (aged 2-8 years) who were born preterm between January 1995 and December 2001. All had been previously admitted to our neonatal intensive care unit at F32 weeks' gestational age (GA) with a birth weight -1500 g. Children with chromosomal or congenital abnormalities, as well as those who suffered BPD after birth, were excluded from the study. In the current study, BPD was defined as the need for supplemental oxygen at a postnatal age of 28 days with typical radiologic changes w2x, and respiratory distress syndrome (RDS) was diagnosed by the clinical presentation and changes on chest imaging w19x. Significant patent ductus arteriosus (PDA) included cases which required medical or surgical intervention. A maternal history of clinical chorioamnionitis was defined as one or more of the following: (i) persistent maternal fever G37.58C on two or more occasions G1 h apart, or a single temperature G388C, prior to delivery, (ii) maternal leukocytosis G20,000/mL, or (iii) foul smelling amniotic fluid w34x. Postnatal sepsis was specified as a positive blood culture with clinical symptoms or signs of infection. All participants were followed-up at our outpatient clinics.
Parents of the enrolled children were invited by mail to answer the International Study of Asthma and Allergies in Childhood (ISAAC) Core Questionnaire Wheezing Module for 6-7 years children (Table 1) . Those who did not initially respond were sent a second questionnaire. Children were categorized as having asthma or not on the basis of ''Yes'' answers to questions 1 and 6. Children with current active wheezing were those who had experienced For each subject, we also collected information regarding family history of atopy (allergic rhinitis or bronchial asthma in first-degree relatives), passive exposure to tobacco smoke (defined as a family member living with the child who currently smokes indoors), and indoor feeding of cats or dogs.
Basic study subject characteristics (in both the asthma and nonasthma groups) were first described by mean and standard deviation (SD) or median (range) for continuous variables, and numbers for categorical factors. Differences between groups for continuous and categorical variables were assessed by independent t-and x 2 -tests. If the number of any category was -5, Fisher's exact tests were performed. To assess the determinants of asthma occurrence, univariate analyses by logistic regressions were applied to estimate the relative risk of each variable for the diagnosis of asthma. Separate multivariate analyses were then performed for GA and gender (these factors displayed high co-linearity) with the various significant factors identified by univariate analyses as well as age at assessment and gender. Birth weight and GA were assessed as categorical variables, in tertiles. In tertiles, these two continuous variables were categorized by 33% percentiles which transformed the small unit to a bigger one, maximized statistical power, and made a test for trend possible to detect a ''dose-response relation''. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the relative risk of asthma. All statistical analyses were performed using SPSS 13.0 for Windows. The significance level was set as 0.05.
Results
There was a 74% response rate (117 out of the 158 VLBW infants identified) to the questionnaires. GA ranged from 22 to 32 weeks. Just -50% of the subjects were male. Those who did not respond to the questionnaires were more likely to suffer from retinopathy of prematurity compared with those who completed the questionnaires. There were no significant differences in other perinatal characteristics including GA, birth weight, birth year, use of antenatal steroids, RDS, PDA and sepsis episodes between the questionnaire responders and non-responders. Of the 117 patients, 80 (68.4%) had received antenatal steroids and 63 of them completed at least one course of steroids 24 h before delivery. Infants who received antenatal steroids had a significantly lower incidence of severe RDS with surfactant therapy than infants without antenatal steroids treatment (4/80 vs. 9/37, Ps0.004). In our hospital, excluding uncontrolled premature labor, all VLBW newborns were born by elective cesarean section due to safety considerations. Therefore, 93 out of the 117 enrolled infants (79.5%) were born by cesarean section. A total of 22 premature infants had TTN, but infants born by cesarean section did not have a significantly higher risk Indicates a statistically significant difference between groups (P-0.05).
of developing TTN compared with infants born by NSD (20.4% vs. 12.5% Ps0.559).
Twenty-two of the children (18.8%) had asthma. Twentyfive of the children (21.4%) had 31 hospitalizations for acute bronchiolitis before age 2 years including 8 episodes of RSV. Table 2 presents descriptive statistics for the study subjects grouped according to whether or not they suffered from asthma. The following variables were statistically different between the groups: total admission duration, antenatal steroid treatment, history of acute bronchiolitis, night cough, and a family history of atopy. There were no statistically significant differences detected regarding GA or birth weight. In an attempt to increase statistical power, tertiles (i.e., 33% percentiles) were calculated and compared for these two continuous variables, however, there were still no significant differences (Table 2 ). There were insufficient cases for analysis of gestational diabetes mellitus, maternal preeclampsia, clinical chorioamnionitis, retinopathy of prematurity and intraventricular hemorrhage in each group.
The univariate analysis is presented in Table 3 . There was an increased risk of asthma detected for history of acute bronchiolitis, night cough, family history of atopy and antenatal steroid treatment. As acute bronchiolitis and night cough are asthma-related symptoms, rather than underlying causes per se, they were not included as factors for the multivariate analyses.
As already noted, birth weight and gestation age at birth were considered confounding factors and not included together for multivariate analyses. Findings from the multivariate analysis including GA and the other factors of interest are presented in Table 4 . Antenatal steroid treatment and family history of atopy remained significant risk factors. With regards to the multivariate analysis incorporating birth weight (Table 5) , antenatal steroid exposure and family history of atopy were also found to be significant.
Discussion
While previous studies identified BPD and VLBW to be significant risk factors for the development of later pulmonary dysfunction and asthma, no studies to date have solely assessed asthma risk factors in VLBW children who did not suffer from BPD. In this study, we examined a cohort of VLBW infants unaffected by BPD. We found that a family history of atopy was a positive risk factor, and maternal antenatal steroid treatment a negative risk factor for later development of asthma.
Asthma has become a leading cause of morbidity among children over the past 20 years w33x. In southern Taiwan, the prevalence of childhood asthma rose by ;30% from 1993 to 1997 w33x. Although the diagnosis of childhood asthma lacks a standard criterion, the ISAAC Core Questionnaire can provide useful, valid, and comparable data about the prevalence of asthma in children w27x. Using the ISAAC core questionnaire, we found the incidence of asthma to be ;19% in our VLBW population. This is in comparison to the worldwide incidence of 10% w36x, and in Taiwan, 7% w21x. This is significantly less than the rate reported by Ng et al. in VLBW children (44%) w25x, but is comparable to that noted by Palta and colleagues (19%) in VLBW children w26x. Asthma was diagnosed using the ISAAC questionnaire in both of these studies, and the children were of similar age to those in our investigation (somewhat older in the Palta et al. study). Although Ng et al. did not present information regarding BPD w25x, presumably a high percentage of the studied VLBW subjects were afflicted, thus explaining the very high overall asthma incidence.
Respiratory morbidity, especially childhood asthma after premature delivery, has a multifactorial etiology w17x. Airway hyperresponsiveness and airway obstruction are consistently found in children born prematurely, even in those without neonatal pulmonary diseases, such as RDS or BPD w7, 8, 20, 30x. Whether this increased responsiveness is due to secondary neonatal lung injury or anatomically small airways is still unclear w7, 27x. A number of previous studies have suggested that there is an inverse relationship between GA and childhood asthma risk. For instance, Bernsen and colleagues determined that asthma risk was inversely related to GA at birth in 6-year-old children w3x. Gessner and Chimonas also found that preterm birth was predictive of later asthma occurrence in children -10 years of age w16x. Contrary to these studies, infants at the lower end of the GA spectrum were no worse off than those at the higher end in terms of asthma risk in our cohort of VLBW subjects. This suggests that there might be a cut-off point for GA, where further decreases do not result in a higher risk for asthma.
Other studies have suggested that birth weight per se rather than GA is an important risk factor for later airway hyperresponsiveness and asthma w20, 30x. Agosti and colleagues found that asthma risk increased with decreasing birth weight in VLBW infants w1x. However, the subjects were not differentiated with respect to being afflicted with BPD. We did not find that birth weight within our VLBW population was predictive of childhood asthma. If indeed there is an effect of birth weight on asthma susceptibility, our findings suggest that within the VLBW categorization there is little variation.
Our study found that preterm infants with TTN did not have a higher risk of developing childhood asthma. Contrary to our findings, Birnkrant et al. found that TTN was independently associated with childhood asthma, and they hypothesized that TTN may be a marker of deficient pulmonary function reflecting inherited susceptibility to asthma w6x. A possible explanation for our difference is that our enrolled candidates were all extremely premature infants with immature pulmonary structure and function. It is difficult to distinguish TTN from mild RDS. In addition, our case numbers were limited and a very small proportion of infants were born vaginally. More studies are needed to establish whether TTN in extremely preterm neonates relates to subsequent childhood asthma.
A family history of atopy exerts antenatal effects on the fetal immune system, causing a shift to responses biased toward those of T helper 2 cells w11x. A parental (especially maternal) history of allergy and asthma is widely accepted In keeping with these findings, we noted a strong association between familial atopy and asthma risk in our population of VLBW subjects. An unexpected finding in our study was that antenatal maternal steroid therapy was an independent protective factor against childhood asthma in children who were VLBW infants. Such a finding has not been previously reported. Contrary to our findings, Grischkan et al. found that there was an increased risk for asthma in 8-11-year-old children who were born preterm (F36 weeks) and treated with postnatal steroids w17x, whereas Palta et al. reported a borderline significant protective effect of antenatal steroid treatment on wheezing in 8-year-old VLBW children w26x. Dalziel et al. found that antenatal exposure to a single course of betamethasone dose not alter prevalence of wheezes and asthma at age 30 years, but only 14% of their participants were born at -1500 g w9x. From these findings (including ours) it would appear that antenatal and postnatal steroid treatment might have differing effects on asthma risk. A likely explanation for our finding is that antenatal steroid therapy may have enhanced lung maturation and therefore minimized secondary pulmonary injury caused by mechanical ventilation and supplemental oxygen. Indeed, antenatal steroids are well known to reduce the occurrence of RDS w22, 28, 29x. Additional studies in different populations are warranted to further explore the impact of steroid treatment on asthma prevalence.
There is some limitation to our study. Because asthma may be difficult to identify in children with previous BPD, our study excluded infants with BPD and we required both a doctor's diagnosis and current wheezes to be classified as asthmatic. However, because analyses were based on children born prematurely with a wide range of ages (from 2 to 8 years) at assessment, we cannot determine whether or not these perinatal effects on asthma are primarily mediated through increased susceptibility to lower respiratory tract infections during infancy. Further investigations should be done to differentiate infection related wheeze from atopic wheeze in these children.
In summary, we have presented an analysis of the risk factors for childhood asthma in VLBW children without BPD. We demonstrated that maternal antenatal steroid treatment was associated with a protective effect in terms of asthma occurrence whereas a familial history of atopy was predictive for childhood asthma in our cohort. The finding regarding the protective effect of antenatal steroids warrants further investigation in other populations, including those who suffered BPD after birth.
